Search

everythinglearnresearchcommunity

for

Search:↓

Combining probiotics, clotrimazole gel, and laser therapy improves treatment for recurrent yeast infections.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

The curly mutation in SELH/Bc mice affects hair and may help study human genetic disorders.

Corneal regeneration relies on distinct stem cell compartments in the limbal niche.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Large language models struggle with accurate clinical decision-making compared to real-world needs.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

The new microrhizotron tool effectively observes and measures pepper plant roots non-destructively.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Radiofrequency devices effectively tighten skin without surgery.

Polycomb Repressive Complex 1 is crucial for keeping stem cells stable and maintaining healthy adult tissues.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional methods for cell therapy.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

A novel CLDN1 mutation in a 2-month-old with NISCH showed improvement with symptom management.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.